SPG3A: An additional family carrying a new atlastin mutation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12499504.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors report on a novel frameshift mutation (c.1688insA) in the SPG3A gene resulting in premature translation termination of the gene product atlastin. These data add a new variant to the second disease gene in autosomal dominant hereditary spastic paraplegia (ADHSP) and lend definitive support to its causative role. By combining direct testing of SPAST and SPG3A, at least 50% of ADHSP families can now receive appropriate genetic diagnosis.
Medical subject headings
- Frameshift Mutation
- GTP Phosphohydrolases
- Spastic Paraplegia, Hereditary